{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:32:23Z","timestamp":1792517543833,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T00:00:00Z","timestamp":1363737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s40272-013-0009-5","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T10:59:43Z","timestamp":1363690783000},"page":"151-162","source":"Crossref","is-referenced-by-count":32,"title":["The Cost Effectiveness of Licensed Oromucosal Midazolam (Buccolam\u00ae) for the Treatment of Children Experiencing Acute Epileptic Seizures: An Approach When Trial Evidence is Limited"],"prefix":"10.1007","volume":"15","author":[{"given":"Dawn","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gladwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nic","family":"Brereton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,20]]},"reference":[{"key":"9_CR1","unstructured":"European Medicines Agency. Buccolam\u00ae 2.5\u00a0mg oromucosal solution: summary of product characteristics [online]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002267\/WC500112310.pdf . Accessed 30 Aug 2012."},{"issue":"9531","key":"9_CR2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","volume":"368","author":"RF Chin","year":"2006","unstructured":"Chin RF, Neville BG, Peckham C, Bedford H, Wade A, Scott RC. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368(9531):222\u20139.","journal-title":"Lancet"},{"issue":"9","key":"9_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1474-4422(06)70546-4","volume":"5","author":"M Raspall-Chaure","year":"2006","unstructured":"Raspall-Chaure M, Chin RF, Neville BGR, Scott RC. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5(9):769\u201379.","journal-title":"Lancet Neurol"},{"issue":"4","key":"9_CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","volume":"12","author":"L Forsgren","year":"2005","unstructured":"Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe: a systematic review. Eur J Neurol. 2005;12(4):245\u201353.","journal-title":"Eur J Neurol"},{"key":"9_CR5","unstructured":"SEIN, WHO Collaborating Centre for Research, Training and Treatment in Epilepsy, WHO headquarters, ILAE\/IBE\/WHO Global Campaign Against Epilepsy. Epilepsy in the WHO European region: fostering epilepsy care in Europe [online]. http:\/\/www.ibe-epilepsy.org\/downloads\/EUROReport160510.pdf . Accessed 30 Aug 2012."},{"key":"9_CR6","unstructured":"World Health Organization. Epilepsy fact sheet No 999 (01\/2009) [online]. http:\/\/www.who.int\/mediacentre\/factsheets\/fs999\/en\/index.html . Accessed 15 Aug 2012."},{"key":"9_CR7","unstructured":"Joint Epilepsy Council. Epilepsy prevalence, incidence and other statistics [online]. http:\/\/www.epilepsyscotland.org.uk\/pdf\/Joint_Epilepsy_Council_Prevalence_and_Incidence_September_11_(3).pdf (2011). Accessed 30 Aug 2012."},{"issue":"5 suppl","key":"9_CR8","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/0883073807303064","volume":"22","author":"JM Pellock","year":"2007","unstructured":"Pellock JM. Overview: definitions and classifications of seizure emergencies. J Child Neurol. 2007;22(5 suppl):9S\u201313S.","journal-title":"J Child Neurol"},{"key":"9_CR9","doi-asserted-by":"crossref","unstructured":"Klimach VJ; Epic Clinical Network. The community use of rescue medication for prolonged epileptic seizures in children. Seizure. 2009;18(5):343\u20136.","DOI":"10.1016\/j.seizure.2008.12.002"},{"issue":"9153","key":"9_CR10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","volume":"353","author":"RC Scott","year":"1999","unstructured":"Scott RC, Besag MF, Neville BG. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet. 1999;353(9153):623\u20136.","journal-title":"Lancet"},{"issue":"2","key":"9_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/088307388900400210","volume":"4","author":"CS Camfield","year":"1989","unstructured":"Camfield CS, Camfield PR, Smith E, Dooley JM. Home use of rectal diazepam to prevent status epilepticus in children with convulsive disorders. J Child Neurol. 1989;4(2):125\u20136.","journal-title":"J Child Neurol"},{"issue":"3","key":"9_CR12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pediatrneurol.2005.03.005","volume":"33","author":"C O\u2019Dell","year":"2005","unstructured":"O\u2019Dell C, Shinnar S, Ballaban-Gil KR, et al. Rectal diazepam gel in the home management of seizures in children. Pediatr Neurol. 2005;33(3):166\u201372.","journal-title":"Pediatr Neurol"},{"key":"9_CR13","unstructured":"Delphi survey of the current clinical practice in Wales for the treatment of prolonged acute convulsive seizures in children and adolescents. Brussels: ViroPharma SPRL-BVBA; 2011 (Data on File)."},{"issue":"1","key":"9_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/adc.2002.019836","volume":"89","author":"MT Wilson","year":"2004","unstructured":"Wilson MT, Macleod S, O\u2019Regan ME. Nasal\/buccal midazolam use in the community. Arch Dis Child. 2004;89(1):50\u20131.","journal-title":"Arch Dis Child"},{"issue":"9166","key":"9_CR15","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(05)75898-0","volume":"353","author":"A Chattopadhyay","year":"1999","unstructured":"Chattopadhyay A, Morris B, Blackburn L, et al. Buccal midazolam and rectal diazepam for epilepsy. Lancet. 1999;353(9166):1798.","journal-title":"Lancet"},{"key":"9_CR16","unstructured":"Pharmaceutical Services Negotiating Committee. Unlicensed specials and imports FAQs [online]. http:\/\/www.psnc.org.uk\/publications_detail.php\/285\/unlicensed_specials_and_imports_guidance (2011). Accessed 30 Aug 2012."},{"key":"9_CR17","unstructured":"General Medical Council. Good Practice in Prescribing Medicines [online]. Available from URL: http:\/\/www.gmc-uk.org\/guidance\/ethical_guidance\/prescriptions_faqs.asp (2008). Accessed 30 Aug 2012."},{"key":"9_CR18","unstructured":"Scottish Medicines Consortium. Midazolam, 5\u00a0mg\/mL oromucosal solution (Buccolam\u00ae) SMC No. (757\/12): ViroPharma Ltd [online]. http:\/\/www.scottishmedicines.org.uk\/SMC_Advice\/Advice\/757_12_midazolam_Buccolam_oromucosal_solution\/midazolam_Buccolam_oromucosal_solution (2012). Accessed 24 Jan 2013."},{"key":"9_CR19","unstructured":"All Wales Medicine Strategy Group (2012). Final Appraisal Recommendation Advice No: 0912. Midazolam (BUCCOLAM\u00ae). Submission by ViroPharma Ltd [online]. http:\/\/www.wales.nhs.uk\/sites3\/Documents\/371\/midazolam%20(Buccolam)%20FAR%20(W).pdf (2012). Accessed 30 Aug 2012."},{"issue":"9481","key":"9_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","volume":"366","author":"J McIntyre","year":"2005","unstructured":"McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366(9481):205\u201310.","journal-title":"Lancet"},{"issue":"1","key":"9_CR21","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1542\/peds.2007-0930","volume":"121","author":"A Mpimbaza","year":"2008","unstructured":"Mpimbaza A, Ndeezi G, Staedke S, et al. Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics. 2008;121(1):e58\u201364.","journal-title":"Pediatrics."},{"issue":"6","key":"9_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","volume":"17","author":"J McMullan","year":"2010","unstructured":"McMullan J, Sasson C, Pancioli A, Silbergleit R. Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010;17(6):575\u201382.","journal-title":"Acad Emerg Med"},{"key":"9_CR23","unstructured":"Patient Survey Wales: Epilepsy rescue medication and your child. ViroPharma SPRL-BVBA; 2011 (Data on File)."},{"issue":"3","key":"9_CR24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","volume":"7","author":"RF Chin","year":"2008","unstructured":"Chin RF, Neville BG, Peckham C, et al. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol. 2008;7(3):696\u2013703.","journal-title":"Lancet Neurol"},{"key":"9_CR25","unstructured":"NHS Business Services Authority. Electronic drug tariff [online]. http:\/\/www.ppa.org.uk\/edt\/January_2013\/mindex.htm . Accessed 24 Jan 2013."},{"key":"9_CR26","unstructured":"Joint Formulary Committee. British National Formulary 64 [online]. http:\/\/www.medicinescomplete.com\/mc\/bnf\/current\/ (2011). Accessed 24 Jan 2013."},{"key":"9_CR27","unstructured":"Department of Health. NHS Reference Costs 2011\u20132012 [online]. http:\/\/www.dh.gov.uk\/health\/2012\/11\/2011-12-reference-costs\/ . Accessed 24 Jan 2013."},{"issue":"4","key":"9_CR28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.yebeh.2012.01.021","volume":"23","author":"A Strzelczyk","year":"2012","unstructured":"Strzelczyk A, Nickolay T, Bauer S, Haag A, Knake S, Oertel WH et al. Evaluation of health-care utilization among adult patients with epilepsy in Germany. Epilepsy Behav. 2012;23(4):451\u20137.","journal-title":"Epilepsy Behav"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-013-0009-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0009-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:43Z","timestamp":1559490283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-013-0009-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,20]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s40272-013-0009-5","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,20]]}}}